Airway (AWM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Airway (AWM) has a cash flow conversion efficiency ratio of 1.059x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-10.68 Million ≈ $-2.94 Million USD) by net assets (zł-10.08 Million ≈ $-2.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Airway - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Airway's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read AWM liabilities breakdown for a breakdown of total debt and financial obligations.
Airway Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Airway ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pharmacielo Ltd
V:PCLO
|
0.236x |
|
Axiom Properties Ltd
AU:AXI
|
-0.145x |
|
LabGenomics Co. Ltd
KQ:084650
|
-0.034x |
|
Eurasia Fonciere Investissements Société Anonyme
PA:EFI
|
-0.015x |
|
Bhandari Hosiery Exports Limited
NSE:BHANDARI
|
0.018x |
|
Falmaco Nonwoven Industri PT Tbk
JK:FLMC
|
-0.007x |
|
Ladangbaja Murni PT Tbk
JK:LABA
|
-0.054x |
|
Bayan Mining and Minerals Ltd
AU:BMM
|
-0.346x |
Annual Cash Flow Conversion Efficiency for Airway (2014–2024)
The table below shows the annual cash flow conversion efficiency of Airway from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see Airway market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | zł-24.32 Million ≈ $-6.69 Million |
zł-7.59 Million ≈ $-2.09 Million |
0.312x | -1.74% |
| 2023-12-31 | zł-13.21 Million ≈ $-3.63 Million |
zł-4.20 Million ≈ $-1.15 Million |
0.318x | +859.23% |
| 2022-12-31 | zł-13.35 Million ≈ $-3.67 Million |
zł-442.00K ≈ $-121.64K |
0.033x | +113.52% |
| 2021-12-31 | zł23.90 Million ≈ $6.58 Million |
zł-5.85 Million ≈ $-1.61 Million |
-0.245x | -233.92% |
| 2020-12-31 | zł30.65 Million ≈ $8.44 Million |
zł-2.25 Million ≈ $-618.68K |
-0.073x | -148.32% |
| 2019-12-31 | zł32.83 Million ≈ $9.04 Million |
zł4.98 Million ≈ $1.37 Million |
0.152x | +265.97% |
| 2018-12-31 | zł34.01 Million ≈ $9.36 Million |
zł-3.11 Million ≈ $-855.92K |
-0.091x | +37.36% |
| 2017-12-31 | zł25.25 Million ≈ $6.95 Million |
zł-3.69 Million ≈ $-1.01 Million |
-0.146x | -17.16% |
| 2016-12-31 | zł24.29 Million ≈ $6.69 Million |
zł-3.03 Million ≈ $-833.07K |
-0.125x | -89.16% |
| 2015-12-31 | zł15.15 Million ≈ $4.17 Million |
zł-998.00K ≈ $-274.66K |
-0.066x | -45.77% |
| 2014-12-31 | zł44.41 Million ≈ $12.22 Million |
zł-2.01 Million ≈ $-552.36K |
-0.045x | -- |
About Airway
Airway Medix S.A. engages in the research, development, and commercialization of medical devices for the mechanically ventilated patients in the intensive care units and for the patients in life-threatening conditions in the anaesthesiology departments in Poland and internationally. It offers Closed Suction System, a dual operation of balloon swiping and suction; Oral Care for intubated hospital … Read more